Previous 10 | Next 10 |
Silverback Therapeutics ( NASDAQ: SBTX ) said the U.S. Food and Drug Administration (FDA) accepted for review ARS Pharmaceuticals' application seeking approval of nasal spray neffy as emergency treatment of allergic reactions (type I) including anaphylaxis in adu...
neffy has potential to be the first non-injectable medicine indicated to treat allergic reactions (type I) including anaphylaxis in the U.S., if approved Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”) today announced that the U.S. Food ...
NEW YORK, NY / ACCESSWIRE / September 30, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Silverback Therapeutics, Inc. (...
NEW YORK, NY / ACCESSWIRE / September 22, 2022 / New York, New York-Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: EVO Payments...
Top Penny Stocks To Watch At The End Of July Should you invest in penny stocks? That’s an excellent question, especially if you’re confident trading higher volatility stocks. The definition of penny stocks includes stocks under $5, and with that low price can come fier...
NEW YORK, NY / ACCESSWIRE / July 28, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Hanger, Inc. (NYSE:HNGR)'s sale to...
NEW YORK, NY / ACCESSWIRE / July 26, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Hanger, Inc. (NYSE:HNGR)'s sale to...
Gainers: Hanger HNGR +25% . Community Health Systems ( CYH ) +19% . HCA Healthcare HCA +14% . LumiraDx ( LMDX ) +11% . Tenet Healthcare ( THC ) +9% . Losers: VistaGen Therapeutics VTGN -84% . Addex Therapeutics ADXN ...
Snap ( SNAP ) -31% on Q2 earnings release . Faraday Future Intelligent Electric ( FFIE ) -16% . Intuitive Surgical ( ISRG ) -11% on Q2 earnings release . Seagate Technology ( STX ) -10% on Q4 earnings release . Creatd ( CRTD ...
Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of chronic viral infections, cancer, and othe...
News, Short Squeeze, Breakout and More Instantly...
Silverback Therapeutics Inc. Company Name:
SBTX Stock Symbol:
NASDAQ Market:
EURneffy positioned to be the first and only needle-free adrenaline option authorized for emergency treatment of allergic reactions (anaphylaxis) in Europe Positive CHMP opinion and recommendation for approval of a mixed application for marketing authorization based on comprehensi...
neffy ® (epinephrine nasal spray) New Drug Application (NDA) and CRL response under review by FDA with anticipated review completion by early October 2024 Response submitted for neffy Marketing Authorization Application (MAA) to EMA’s CHMP; CHMP...
CHMP opinion on neffy Marketing Authorization Application anticipated in the second quarter of 2024 Response addresses all issues previously identified by CHMP, and includes results from a repeat dose PK/PD study of neffy under NAC conditions and updated ...